Sílvia Ribeiro Coutinho1, Emilie With2, Jens F Rehfeld3, Bård Kulseng4, Helen Truby5, Cátia Martins4. 1. Obesity Research Group, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway. Electronic address: silvia.coutinho@ntnu.no. 2. Obesity Research Group, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway. 3. Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 4. Obesity Research Group, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Centre for Obesity, Department of Surgery, St. Olav Hospital, Trondheim University Hospital, Trondheim, Norway. 5. Department of Food, Nutrition and Dietetics, Monash University, Melbourne, Australia.
Abstract
BACKGROUND & AIMS: Rapid weight loss (WL) has been associated with a larger loss of fat free mass and a disproportional reduction in resting metabolic rate (RMR), but the evidence is inconclusive. We aimed to evaluate the impact of WL rate on body composition and compensatory mechanisms activated with WL (reduced RMR, increased exercise efficiency (ExEff) and appetite), both during negative and neutral energy balance (EB). METHODS:Thirty-five participants with obesity were randomized to lose a similar weight rapidly (4 weeks) or gradually (8 weeks), and afterwards to maintain it (4 weeks). Body weight and composition, RMR, ExEff (10, 25 and 50 W), appetite feelings and appetite-regulating hormones (active ghrelin, cholecystokinin, total peptide YY (PYY), active glucagon-like peptide-1 and insulin), in fasting and every 30 min up to 2.5 h, were measured at baseline and after each phase. RESULTS: Changes in body weight (≈9%) and composition were similar in both groups. With WL, RMR decreased and ExEff at 10 W increased significantly in the rapid WL group only. However, fasting hunger increased significantly with gradual WL only, while fasting and postprandial prospective food consumption, and postprandial hunger decreased (and postprandial fullness increased) significantly with rapid WL only. Basal total PYY, and basal and postprandial insulin decreased significantly, and similarly in both groups. After weight stabilization and no ketosis no differences between groups were found. CONCLUSIONS: Despite differences while under negative EB, WL rate does not seem to have a significant impact on body composition or on compensatory mechanisms, once EB is reestablished. CLINICAL TRIAL REGISTRATION NUMBER: NCT01912742 (the study was registered in clinicaltrial.gov).
RCT Entities:
BACKGROUND & AIMS: Rapid weight loss (WL) has been associated with a larger loss of fat free mass and a disproportional reduction in resting metabolic rate (RMR), but the evidence is inconclusive. We aimed to evaluate the impact of WL rate on body composition and compensatory mechanisms activated with WL (reduced RMR, increased exercise efficiency (ExEff) and appetite), both during negative and neutral energy balance (EB). METHODS: Thirty-five participants with obesity were randomized to lose a similar weight rapidly (4 weeks) or gradually (8 weeks), and afterwards to maintain it (4 weeks). Body weight and composition, RMR, ExEff (10, 25 and 50 W), appetite feelings and appetite-regulating hormones (active ghrelin, cholecystokinin, total peptide YY (PYY), active glucagon-like peptide-1 and insulin), in fasting and every 30 min up to 2.5 h, were measured at baseline and after each phase. RESULTS: Changes in body weight (≈9%) and composition were similar in both groups. With WL, RMR decreased and ExEff at 10 W increased significantly in the rapid WL group only. However, fasting hunger increased significantly with gradual WL only, while fasting and postprandial prospective food consumption, and postprandial hunger decreased (and postprandial fullness increased) significantly with rapid WL only. Basal total PYY, and basal and postprandial insulin decreased significantly, and similarly in both groups. After weight stabilization and no ketosis no differences between groups were found. CONCLUSIONS: Despite differences while under negative EB, WL rate does not seem to have a significant impact on body composition or on compensatory mechanisms, once EB is reestablished. CLINICAL TRIAL REGISTRATION NUMBER: NCT01912742 (the study was registered in clinicaltrial.gov).
Authors: Gabriel P Esteves; Bruna Caruso Mazzolani; Fabiana Infante Smaira; Elizabeth Silva Mendes; Gabriela Guimarães de Oliveira; Hamilton Roschel; Bruno Gualano; Rosa Maria R Pereira; Eimear Dolan Journal: Rheumatol Adv Pract Date: 2022-04-21
Authors: Tanya M Halliday; Sarit Polsky; Jonathan A Schoen; Kristina T Legget; Jason R Tregellas; Kayla M Williamson; Marc-Andre Cornier Journal: Physiol Rep Date: 2019-04
Authors: S Nymo; S R Coutinho; P H Eknes; I Vestbostad; J F Rehfeld; H Truby; B Kulseng; C Martins Journal: Int J Obes (Lond) Date: 2018-06-21 Impact factor: 5.095
Authors: Radhika V Seimon; Anthony L Wild-Taylor; Shelley E Keating; Sally McClintock; Claudia Harper; Alice A Gibson; Nathan A Johnson; Hamish A Fernando; Tania P Markovic; Jacqueline R Center; Janet Franklin; Peter Y Liu; Stuart M Grieve; Jim Lagopoulos; Ian D Caterson; Nuala M Byrne; Amanda Sainsbury Journal: JAMA Netw Open Date: 2019-10-02